Delonix Bioworks Closes $14 Million Series Seed Financing to Accelerate the Development of its Innovative Synthetic Vaccines ...Middle East

SHANGHAI, March 11, 2021 /PRNewswire/ -- Delonix Bioworks Ltd. (Delonix), a biotechnology company dedicated to developing the next generation vaccines with synthetic biology approaches, has recently closed a $14 million Series Seed financing led by Boehringer Ingelheim Venture Fund (BIVF)...

Hence then, the article about delonix bioworks closes 14 million series seed financing to accelerate the development of its innovative synthetic vaccines was published today ( Thursday 11/03/2021 - 04:48 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Delonix Bioworks Closes $14 Million Series Seed Financing to Accelerate the Development of its Innovative Synthetic Vaccines )

Also on site :

• Fiery crash near Modesto leaves 1 dead, several injured
• Reciprocal strikes disrupt US–Iran talks in Switzerland
• Heightened emotions in Iran after Team Melli knocked out of World Cup